2024-12-24 03:57:28
Author: HanAll Biopharma and Daewoong Pharmaceutical / 2023-07-24 00:17 / Source: HanAll Biopharma and Daewoong Pharmaceutical

/DISREGARD RELEASE: HanAll Biopharma and Daewoong Pharmaceutical/

We are advised by HanAll Biopharma and Daewoong Pharmaceutical that journalists and other readers should disregard the news release,"Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative",issued 11-Apr-2022 over PR Newswire.

Tags: Health Care/Hospital Medical/Pharmaceuticals Pharmaceuticals

Previous:

Next:

Leave a comment

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release